151 related articles for article (PubMed ID: 9111066)
1. Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway.
Furuya KN; Thottassery JV; Schuetz EG; Sharif M; Schuetz JD
J Biol Chem; 1997 Apr; 272(17):11518-25. PubMed ID: 9111066
[TBL] [Abstract][Full Text] [Related]
2. Sp1 and egr-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene.
Thottassery JV; Sun D; Zambetti GP; Troutman A; Sukhatme VP; Schuetz EG; Schuetz JD
J Biol Chem; 1999 Jan; 274(5):3199-206. PubMed ID: 9915860
[TBL] [Abstract][Full Text] [Related]
3. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.
Nair VD; Sealfon SC
J Biol Chem; 2003 Nov; 278(47):47053-61. PubMed ID: 12970364
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells.
Zhou G; Kuo MT
J Biol Chem; 1997 Jun; 272(24):15174-83. PubMed ID: 9182539
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
6. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids.
Schuetz JD; Silverman JA; Thottassery JV; Furuya KN; Schuetz EG
Cell Growth Differ; 1995 Oct; 6(10):1321-32. PubMed ID: 8845310
[TBL] [Abstract][Full Text] [Related]
7. A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase.
Cornwell MM; Smith DE
J Biol Chem; 1993 Jul; 268(21):15347-50. PubMed ID: 8101839
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Kanki R; Yamashita H; Akaike A
J Neurosci Res; 2002 Nov; 70(3):274-82. PubMed ID: 12391586
[TBL] [Abstract][Full Text] [Related]
9. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene.
Liu JC; Baker RE; Sun C; Sundmark VC; Elsholtz HP
J Biol Chem; 2002 Sep; 277(39):35819-25. PubMed ID: 12121979
[TBL] [Abstract][Full Text] [Related]
10. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling.
Kuo MT; Liu Z; Wei Y; Lin-Lee YC; Tatebe S; Mills GB; Unate H
Oncogene; 2002 Mar; 21(13):1945-54. PubMed ID: 11960367
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney.
Narkar V; Kunduzova O; Hussain T; Cambon C; Parini A; Lokhandwala M
Kidney Int; 2004 Aug; 66(2):633-40. PubMed ID: 15253716
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
Wang C; Buck DC; Yang R; Macey TA; Neve KA
J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells.
Narkar VA; Hussain T; Pedemonte C; Lokhandwala MF
J Am Soc Nephrol; 2001 Sep; 12(9):1844-1852. PubMed ID: 11518777
[TBL] [Abstract][Full Text] [Related]
14. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation.
Brami-Cherrier K; Valjent E; Garcia M; Pagès C; Hipskind RA; Caboche J
J Neurosci; 2002 Oct; 22(20):8911-21. PubMed ID: 12388598
[TBL] [Abstract][Full Text] [Related]
15. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.
Chiasson K; Daoust B; Levesque D; Martinoli MG
Neurotox Res; 2006 Aug; 10(1):31-42. PubMed ID: 17000468
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human PRL-releasing peptide (PrRP) receptor gene by a dopamine 2 Receptor agonist: cloning and characterization of the human PrRP receptor gene and its promoter region.
Ozawa A; Yamada M; Satoh T; Monden T; Hashimoto K; Kohga H; Hashiba Y; Sasaki T; Mori M
Mol Endocrinol; 2002 Apr; 16(4):785-98. PubMed ID: 11923475
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
Sands SA; Dickerson DS; Morris SJ; Chronwall BM
Endocrine; 1997 Jun; 6(3):325-33. PubMed ID: 9368690
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
